ADAR1 Capital Management »

Nuvalent Inc-a shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Nuvalent Inc-a (NUVL) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Nuvalent Inc-a

23:59:59.999Sep 29, 202423:59:59.999500:00:00Sep 30, 202400:00:00.000500:00:00.0011.068215M1.0682155M1.068216M1.0682165M1.068217M10.441k10.4415k10.442k10.4425k10.443k
Value ($)Share countHistorical NUVL position of ADAR1 Capital Management Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Nuvalent Inc-a held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nuvalent Inc-a by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.1M 10k 102.30

More positions owned by ADAR1 Capital Management

Cytokinetics Com New (CYTK)
Protagonist Therapeutics (PTGX)
Bridgebio Pharma (BBIO)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Immunovant (IMVT)
Royalty Pharma Shs Class A (RPRX)
Keros Therapeutics (KROS)
Ascendis Pharma A/s Sponsored Adr (ASND)
Zura Bio Class A Ord Shs (ZURA)
Zai Lab Adr (ZLAB)
Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA)
Aa Mission Acquisition Corp Ord Shs Cl A (AAM)
Mineralys Therapeutics (MLYS)
Syndax Pharmaceuticals (SNDX)

View all positions for ADAR1 Capital Management

Top funds holding Nuvalent Inc-a

Deerfield Management Company
FMR
Paradigm Biocapital Advisors
Vanguard Group
BlackRock
Perceptive Advisors
State Street Corporation
Bain Capital Life Sciences Investors
Fairmount Funds Management
T. Rowe Price Associates
Wellington Management Company
Woodline Partners
Boxer Capital Management
Commodore Capital
Geode Capital Management

View all funds holding Nuvalent Inc-a